Advertisement

Science Translational Medicine

  • Volume 14
  • Issue 667
  • 19 Oct 2022
Go to Science Translational Medicine
Go to Science Translational Medicine

ONLINE COVER Tracking TAMs. This two-photon microscopy image shows uptake of perfluorocarbon-containing nanoparticles (PFC-NPs; red) by tumor-associated microglia and macrophages (TAMs) in a central nervous system (CNS) tumor. Vasculature is shown in yellow and tumor cells are shown in green. Increased TAM abundance in CNS tumors has been correlated to more aggressive disease; however, monitoring these cells in patients has only been achievable using invasive biopsies. Here, Croci et al. showed that CNS TAMs could be monitored by magnetic resonance imaging (MRI) for PFC-NPs enriched for the stable isotope, fluorine-19 (19F). The authors found that TAMs could be tracked longitudinally and in response to radiotherapy, highlighting the potential of 19F MRI as a monitoring strategy for patients with CNS tumors.

Credit: Davide Croci and Johanna Joyce, University of Lausanne, Switzerland

Advertisement

Focus

ABOUT

Science Translational Medicine is the leading weekly online journal publishing research at the intersection of science, engineering and medicine. The goal of Science Translational Medicine is to promote human health by providing a forum for communicating the latest research advances from biomedical, translational, and clinical researchers from all established and emerging disciplines relevant to medicine.

mission & scope

Advertisement

Podcasts

Advertisement

Advertisement